News
A federal appeals court has upheld a lower court’s decision to restrict abortion pill sales in West Virginia. A three-judge ...
2d
Zacks Investment Research on MSNMerck Starts Phase III Studies on Once-Monthly Pill for HIV PreventionMerck MRK recently launched two late-stage clinical studies to evaluate MK-8527, its investigational once-monthly oral pill for HIV pre-exposure prophylaxis (PrEP). The EXPrESSIVE-11 study, which ...
PillTrek is a mini capsule that senses gut biomarkers in real time. It enables advanced GI diagnostics without invasive ...
This new FDA-approved shot is designed to break down the barriers that have kept too many people from accessing PrEP.
6d
Zacks Investment Research on MSNFDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV PillMerck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results